Checkmate by a Protean Invisible Enemy. Covid-19 the Danger Within

Despite the fact that COVID-19 primarily infects the lower respiratory track, COVID-19 deaths are primarily clustered around cardiovascular disease (CVD), diabetes and obesity. These disorders’ common denominators are high VLDL cholesterol, triglycerides, inflammation and increased visceral adipose tissue. Obesity, CVD and diabetes are also associated with increased Free T3 and cortisol abnormalities. Abdominal obesity has respiratory problems which contribute to the burden of respiratory disease. Exercise enhances detoxification improves immunity and promotes cardiorespiratory fitness (CRF) proving to be an effective therapy for most chronic diseases. During COVID-19 lockdown or quarantine, however, gyms and other exercise facilities are closed. In search of solutions that can proactively protect public health, this randomized double-blind within subjects trial examines the effects of a new effortless exercise technology on healthy subjects (before implementing it on COVID-19 patients) on visceral adipose tissue, that entails inflammation and toxicity, high VLDL cholesterol, triglycerides, abnormalities in T3 and cortisol. Results indicate that effortless exercise, originally invented and built in London University, can serve as an alternative to physical exercise in decreasing visceral adipose tissue, lower VLDL and triglycerides, increase skeletal muscle mass and Free T3, without unbalancing or stressing the body with increased cortisol levels.